The urethral caruncle is a benign tumor of the distal urethral mucosa, almost exclusively found in females, that develops on the posterior aspect of the meatus. Its diagnosis relies on clinical examination, but several semiological and therapeutic pitfalls deserve particular attention.
Histology of the urethral caruncle and differential diagnoses not to be missed
The urethral caruncle is made up of loose connective tissue, richly vascularized, covered by transitional or malpighian epithelium. This hypervascularization explains the tendency to bleed with minimal contact. We observe three main histological types: papillomatous, angiomatous, and granulomatous, each with a slightly different macroscopic appearance.
Recommended read : Duraboard: everything you need to know about this innovative garden material
The real clinical issue is not the caruncle itself, but what it may conceal. A urethral carcinoma, a prolapse of the urethral mucosa, or a condyloma can mimic a benign caruncle. Any ulcerated, hardened, or recurrent lesion after excision justifies a biopsy. We systematically recommend pathological analysis of the surgical specimen, even when the clinical appearance seems typical.
To better understand the urethral caruncle symptoms and causes, it is important to keep in mind that the clinical presentation varies according to the histological type and the degree of associated inflammation.
See also : Everything You Need to Know About the Taxi Profession and Transportation Services in Poitiers
The role of estrogen deficiency in the urethral caruncle post-menopause
The majority of urethral caruncles occur in postmenopausal women. The drop in estrogen leads to atrophy of the urethral and vaginal mucosa, with a loss of elasticity and increased fragility of the perimeatal tissues. This condition favors the herniation of the urethral mucosa through the meatus.
The genitourinary syndrome of menopause (GSM) constitutes the reference nosological framework. It associates vaginal dryness, dyspareunia, pollakiuria, and recurrent urinary infections. The urethral caruncle fits into this picture of global mucosal atrophy, not as an isolated pathology.
Chronic irritations (hygienic protections, tight clothing, microtraumas related to intercourse) exacerbate the phenomenon on already weakened mucosa. This association explains why local treatment with topical estrogens constitutes the first-line therapy, before any surgical discussion.
Symptoms of the urethral caruncle: what motivates the consultation
The urethral caruncle remains asymptomatic in a significant proportion of cases and is then discovered during examination. When it becomes symptomatic, the clinical picture associates several signs to varying degrees:
- Bleeding on contact or spotting in underwear, often confused with postmenopausal vaginal bleeding
- Pain or burning during urination (dysuria), sometimes wrongly attributed to a cystitis or urinary infection
- Soft, reddish mass visible at the urethral meatus, sensitive to palpation
- Discomfort with direct contact (clothing, sexual intercourse, wiping)
Pain is rarely spontaneous but is constantly provoked by contact. This mechanical nature of the symptoms points towards the caruncle rather than a pure urinary infection, where the pain is mainly during urination.
The most common diagnostic error is treating dysuria related to the caruncle with antibiotics, thinking it is a bacterial infection. A negative urine culture in a postmenopausal woman presenting with dysuria should prompt investigation for a lesion of the meatus.
Treatment of the urethral caruncle: topical estrogens versus surgical excision
The first-line treatment is based on the application of estrogens in cream (estriol or estradiol) directly on the lesion and the peri-urethral mucosa. This local treatment aims to restore mucosal trophicity and reduce the size of the caruncle. The response to topical estrogens is usually achieved within a few weeks in most cases of moderate symptoms.
Topical anti-inflammatories can complement the treatment in cases of marked inflammatory components. Warm sitz baths provide symptomatic relief by reducing local edema.
Surgical excision is discussed in three specific situations:
- Large, symptomatic caruncle despite well-conducted medical treatment for several weeks
- Recurrent or abundant bleeding impacting quality of life
- Diagnostic doubt requiring complete histological analysis of the lesion
The procedure consists of excision at the base, under local or locoregional anesthesia. Suturing the urethral mucosa to the perineal skin reduces the risk of recurrence. Post-surgical recurrence remains possible if the estrogen deficiency is not corrected, which justifies the continuation of local hormonal treatment after the intervention.
Urethral caruncle and recurrent urinary infections: an underestimated link
The urethral caruncle alters urinary flow at the meatus. A large lesion can deflect the stream, promote peri-meatal stasis, and create an environment conducive to bacterial colonization. In postmenopausal women suffering from recurrent cystitis, we systematically look for an anomaly of the meatus.
Treating the caruncle with topical estrogens contributes to the prevention of recurrent urinary infections by restoring the lactobacillus vaginal flora and improving local mucosal defenses. This integrated approach, combining management of genitourinary atrophy and prevention of infections, yields better results than repeated antibiotic treatment.
Treating the urethral caruncle also means addressing the underlying mucosal atrophy. The isolated prescription of antibiotics for recurrent cystitis without examination of the urethral meatus represents a missed therapeutic opportunity for postmenopausal women. A perineal clinical examination remains the key to appropriate management.